2/10
04:05 pm
cbll
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Low
Report
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
1/28
08:41 am
cbll
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $30.00 price target on the stock.
Medium
Report
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $30.00 price target on the stock.
1/14
09:41 am
cbll
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion [Yahoo! Finance]
Low
Report
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion [Yahoo! Finance]
1/5
08:40 am
cbll
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution [Yahoo! Finance]
High
Report
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution [Yahoo! Finance]
1/5
08:00 am
cbll
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
Medium
Report
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
12/30
04:05 pm
cbll
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/17
03:07 pm
cbll
CeriBell (NASDAQ:CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $29.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
CeriBell (NASDAQ:CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $29.00 to $30.00. They now have a "buy" rating on the stock.
12/15
07:20 am
cbll
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at BTIG Research.
Medium
Report
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at BTIG Research.
12/12
09:49 am
cbll
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
Low
Report
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
12/9
12:17 pm
cbll
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Medium
Report
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at Cowen Inc.
12/9
08:00 am
cbll
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
Low
Report
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
11/24
08:00 am
cbll
Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates
Medium
Report
Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates
11/19
04:05 pm
cbll
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference